Zhang Zun, correspondent of Dazhong.com, poster news reporter Chu Fubing Xu Lei reported from Zaozhuang
On June 13, I learned from the Department of Liver Diseases of Xuecheng District People’s Hospital that the hospital was awarded the Shandong Provincial Hospital at the awarding and agreement signing ceremony of the “Shandong Province Integrated Traditional Chinese and Western Medicine Major Project and Shandong Province Liver Cirrhosis Diagnosis and Treatment Alliance Branch Center” on June 11. Plaques for members of the sub-center of the Liver Cirrhosis Diagnosis and Treatment Alliance. The conference was held in Shandong Overseas Chinese Association. The relevant persons in charge of the medical department and liver disease department of the hospital attended the meeting and received plaques.
In recent years, the hospital has taken the development of the infectious disease department as an opportunity and at the same time promoted the development of the liver disease department. Since the liver disease clinic opened in May 2020, more than 4,000 patients with liver disease have been diagnosed and treated. Treatment of viral hepatitis A, B, C and E, drug-induced hepatitis, autoimmune liver disease (AIH, PBC and overlap syndrome), fatty liver disease, alcoholic liver disease, cholestatic liver disease, IgG4-related cholangitis, liver disease Cirrhosis (decompensated) and other patients, as well as acute and critically ill patients such as liver failure, hepatic encephalopathy, gastrointestinal bleeding, hepatorenal syndrome, and spontaneous bacterial peritonitis. Especially in the treatment of liver cirrhosis, staged progress has been made and rich clinical experience has been accumulated.
In the pre-licensing stage, the hospital carefully prepared relevant materials and reported it to the Provincial Liver Cirrhosis Diagnosis and Treatment Alliance. After layers of review by experts from the alliance, it was determined that the hospital’s liver disease diagnosis and treatment level and local influence were in line with the sub-center. conditions, and were awarded the license. The provincial liver cirrhosis diagnosis and treatment alliance branch center was awarded the first batch, and a total of more than 50 hospitals in the province were awarded. It marks that the hospital’s development of liver disease diagnosis and treatment technology has been in line with the advanced level inside and outside the province. In the future, it will be able to facilitate referrals and the assistance of well-known experts inside and outside the province, which effectively promotes the development of specialist academics.
Liver cirrhosis is a chronic progressive liver disease, which is a persistent liver damage caused by long-term or repeated actions of various reasons. In the late stage, complications such as upper gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, secondary infection, and liver cancer will occur, which seriously threaten the lives and health of the people.
It is reported that in addition to being a branch center of the Provincial Liver Cirrhosis Diagnosis and Treatment Alliance, the hospital has also been rated as a “Liver-loving Life-Care Management Project Hospital” by the “China Hepatitis Prevention and Control Foundation”. Joined the “China Research on Reducing the Incidence of Liver Cancer in Hepatitis B Patients (Oasis) Project” and the “China Chronic Hepatitis B Clinical Cure Project (Everest) Project”, and carried out the “Interferon Treatment of Hepatitis B Predominant Patients Clinical Cure” activity. Joint obstetrics and gynecology department to carry out the diagnosis and treatment of hepatitis B mother-infant block and pregnancy cholestasis, and reduce the positive rate of hepatitis B surface antigen (HBsAg) in neonates.